Page - 94 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Image of the Page - 94 -
Text of the Page - 94 -
Conniotet al. Nanocarriers for immunecell targetingand tracking
Zhang, Q., Zhang, A., Yang, P., and Shen, J. (2013). Synthesis of CdSe quantum
dots using various long-chain fatty acids and their phase transfer. J. Nanosci.
Nanotechnol.13,4235–4241.:10.1166/jnn.2013.7433
Zhang, Z., Jiang, Q., Jiang, F., Ding, G., Zhang, R., Wang, L., et al. (2004). In
vivomagnetic resonance imaging tracks adult neural progenitor cell target-
ing of brain tumor.Neuroimage 23, 281–287. doi: 10.1016/j.neuroimage.2004.
05.019
Zhang, Z., Tongchusak, S., Mizukami, Y., Kang, Y. J., Ioji, T., Touma, M.,
et al. (2011). Induction of anti-tumor cytotoxic T cell responses through
PLGA-nanoparticlemediatedantigendelivery.Biomaterials32,3666–3678.doi:
10.1016/j.biomaterials.2011.01.067
Zhou,Y., Zhang,C., andLiang,W. (2014).Development ofRNAi technology for
targetedtherapy-atrackofsiRNAbasedagentstoRNAitherapeutics.J.Control.
Release.doi:10.1016/j.jconrel.2014.04.044. [Epubaheadofprint].
Zitvogel, L., Tesniere, A., and Kroemer, G. (2006). Cancer despite immuno-
surveillance: immunoselection and immunosubversion.Nat. Rev. Immunol. 6,
715–727.doi:10.1038/nri1936
Zou,W. (2005). Immunosuppressive networks in the tumour environment and
their therapeutic relevance.Nat.Rev.Cancer5,263–274.doi:10.1038/nrc1586 Conflict of Interest Statement:The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construedasapotential conflictof interest.
Received: 15 September 2014; accepted: 31 October 2014; published online: 26
November2014.
Citation: Conniot J, Silva JM, Fernandes JG, Silva LC, Gaspar R, Brocchini S,
FlorindoHFandBarataTS(2014)Cancer immunotherapy:nanodeliveryapproaches
for immune cell targeting and tracking. Front. Chem. 2:105. doi: 10.3389/fchem.
2014.00105
Thisarticlewas submitted toChemicalEngineering,a sectionof the journalFrontiers
inChemistry.
Copyright © 2014 Conniot, Silva,Fernandes, Silva,Gaspar,Brocchini,Florindoand
Barata. This is an open-access article distributed under the terms of the Creative
CommonsAttributionLicense(CCBY).Theuse,distributionorreproductioninother
forums is permitted, provided the original author(s) or licensor are credited and that
theoriginalpublication in this journal is cited, inaccordancewithacceptedacademic
practice.Nouse,distributionorreproduction ispermittedwhichdoesnotcomplywith
these terms.
www.frontiersin.org November2014 |Volume2 |Article105 | 94
Cancer Nanotheranostics
What Have We Learnd So Far?
- Title
- Cancer Nanotheranostics
- Subtitle
- What Have We Learnd So Far?
- Authors
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Editor
- Frontiers in Chemistry
- Date
- 2016
- Language
- English
- License
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Size
- 21.0 x 27.7 cm
- Pages
- 132
- Keywords
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Categories
- Naturwissenschaften Chemie